Related references
Note: Only part of the references are listed.Effects of infection history on dengue virus infection and pathogenicity
Tim K. Tsang et al.
NATURE COMMUNICATIONS (2019)
Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Path to a Dengue Vaccine: Learning from Human Natural Dengue Infection Studies and Vaccine Trials
Aravinda M. de Silva et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Controversy and debate on dengue vaccine series-paper 1: review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs
Antonio L. Dans et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2018)
Reconstruction of antibody dynamics and infection histories to evaluate dengue risk
Henrik Salje et al.
NATURE (2018)
Antibody-dependent enhancement of severe dengue disease in humans
Leah C. Katzelnick et al.
SCIENCE (2017)
Vaccines licensed and in clinical trials for the prevention of dengue
J. Torresi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Licensed Dengue Vaccine: Public Health Conundrum and Scientific Challenge
Scott B. Halstead
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2016)
Critique of World Health Organization Recommendation of a Dengue Vaccine
Scott B. Halstead
JOURNAL OF INFECTIOUS DISEASES (2016)
Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses
Donald M. Carter et al.
JOURNAL OF VIROLOGY (2016)
The risks behind Dengvaxia recommendation
Maira Aguiar et al.
LANCET INFECTIOUS DISEASES (2016)
Recognition determinants of broadly neutralizing human antibodies against dengue viruses
Alexander Rouvinski et al.
NATURE (2015)
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
S. R. Hadinegoro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Clinical evaluation strategies for a live attenuated tetravalent dengue vaccine
Alexander Roberto Precioso et al.
VACCINE (2015)
Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward
Bruno Guy et al.
VACCINE (2015)
A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
Wanwisa Dejnirattisai et al.
NATURE IMMUNOLOGY (2015)
Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study
Jorge E. Osorio et al.
LANCET INFECTIOUS DISEASES (2014)
mRNA-based therapeutics - developing a new class of drugs
Ugur Sahin et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Antibody response to dengue virus
Leticia Cedillo-Barron et al.
MICROBES AND INFECTION (2014)
Spatiotemporal Dynamics of DENV-2 Asian-American Genotype Lineages in the Americas
Daiana Mir et al.
PLOS ONE (2014)
Global spread of dengue virus types: mapping the 70 year history
Jane P. Messina et al.
TRENDS IN MICROBIOLOGY (2014)
Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity
Nicholas G. Reich et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2013)
The global distribution and burden of dengue
Samir Bhatt et al.
NATURE (2013)
Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study Year
Magelda Montoya et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
Arunee Sabchareon et al.
LANCET (2012)
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
Ruklanthi de Alwis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus
Oliver J. Brady et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets
Brendan M. Giles et al.
VACCINE (2011)
Virus-like particles in vaccine development
Antonio Roldao et al.
EXPERT REVIEW OF VACCINES (2010)
Structure of the immature dengue virus at low pH primes proteolytic maturation
I-Mei Yu et al.
SCIENCE (2008)
Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking
Hilde M. van der Schaar et al.
JOURNAL OF VIROLOGY (2007)
Selection for virulent dengue viruses occurs in humans and mosquitoes
R Cologna et al.
JOURNAL OF VIROLOGY (2005)
Structure of the dengue virus envelope protein after membrane fusion
Y Modis et al.
NATURE (2004)
The origin, emergence and evolutionary genetics of dengue virus
Edward C. Holmes et al.
INFECTION GENETICS AND EVOLUTION (2003)
Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections
DH Libraty et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Share Paper
